Investor Presentation Dr. Lal PathLabs Ltd - 539524 - Announcement under Regulation 30 (LODR)-Investor Presentation BSE India Attached
Investor Presentation Dr. Lal PathLabs Ltd - 539524 - Announcement under Regulation 30 (LODR)-Investor Presentation BSE India Attached
Investor Presentation Dr. Lal PathLabs Ltd - 539524 - Announcement under Regulation 30 (LODR)-Investor Presentation BSE India Attached
Investor Presentation Dr. Lal PathLabs Ltd - 539524 - Announcement under Regulation 30 (LODR)-Investor Presentation BSE India Attached
Investor Presentation Dr. Lal PathLabs Ltd - 539524 - Announcement under Regulation 30 (LODR)-Investor Presentation BSE India Earnings presentation on the Un-audited Financial Results for the quarter ended June 30, 2025
Investor Presentation Dr. Lal PathLabs Ltd - 539524 - Announcement under Regulation 30 (LODR)-Investor Presentation BSE India Earnings Presentation on Audited Financial Results (Standalone and Consolidated) for the Quarter and Financial Year ended March 31, 2025
Investor Presentation Dr. Lal PathLabs Ltd - 539524 - Announcement under Regulation 30 (LODR)-Investor Presentation BSE India Earnings presentation on Un-audited Financial Results (Standalone and Consolidated) for the Quarter and Nine Months ended December 31 2024
Investor Presentation Dr. Lal PathLabs Ltd - 539524 - Announcement under Regulation 30 (LODR)-Investor Presentation BSE India Investors Presentation for the period ended September 30, 2024
Investor Presentation Dr. Lal PathLabs Ltd - 539524 - Announcement under Regulation 30 (LODR)-Investor Presentation BSE India Earnings presentations on unaudited financial results for quarter ended June 30, 2024
Investor Presentation Dr. Lal PathLabs Ltd - 539524 - Announcement under Regulation 30 (LODR)-Investor Presentation BSE India Investor Presentation for Q4 & FY 24 attached